Novartis Pharmaceuticals Corp., Parsippany, NJ, has awarded Integrated Communications Corp. (ICC) promotion work for a new epilepsy drug called Trileptal.
The budget was not disclosed.
Sal Perreca, President and CEO of Integrated Communications, said “the new assignment from NOVARTIS has helped to increase our Parsippany agency total billings to a record level and our staff to 220 creative, marketing, and medical personnel.
Network
